Australian healthcare players Integral Diagnostics (ASX:IDX) and Capitol Health (ASX:CAJ) should benefit from additional wage indexation in fiscal 2025, while Sonic Healthcare (ASX:SHL) and Healius (ASX:HLS) are expected to remain "hurt" by the lack of indexation, according to a Sept. 18 note from Jarden Research.
Meanwhile, Ramsay Healthcare (ASX:RHC) and Regis Healthcare (ASX:REG) should benefit from lower agency costs, with Ramsay remaining in negotiations on enterprise bargaining agreements in Western Australia and New South Wales, Australia, the investment firm stated.
CSL (ASX:CSL) ResMed (ASX:RMD) has shown margin expansion due to management improving operating margins, with ResMed's initial concern of higher freight costs on margins "more than offset" as expectations it will normalize into fiscal 2025, according to the note.
ResMed, Cochlear (ASX:COH), Regis Healthcare, and Sonic Healthcare appear to Jarden Research to be best positioned for more mergers and acquisitions and capital management, while Healius and Ramsay Healthcare are looking at selling assets to optimize their portfolios, the investment firm said.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。